FOR IMMEDIATE RELEASE
Wednesday, July 29, 2015
CONTACT:
Alissa Manzoeillo
202.667.5881, ext 219; 202.595.4395 (after hours/cell)
amanzoeillo@prochoice.org

 

Statement of Vicki Saporta, President and CEO of the National Abortion Federation (NAF) and NAF Canada:

The approval of mifepristone is great news for women in Canada. Mifepristone has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It’s long overdue that Canadian women also have access to the gold standard for medical abortion care.

NAF worked to help bring the application for mifepristone forward, and has urged Health Canada to approve the medication. NAF members care for more than 80% of the women who choose abortion care in Canada each year, and we will be working with our members so they can offer this option to their patients once mifepristone becomes available in early 2016.

 

# # #

 

NAF is the professional association of abortion providers. Our members include private and non-profit clinics, Planned Parenthood affiliates, women’s health centers, physicians’ offices, and hospitals who together care for more than half the women who choose abortion in the U.S. and Canada each year. Our members also include public hospitals and both public and private clinics in Mexico City and private clinics in Colombia.

Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedInEmail this to someone